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Objective. Here we tested the role of Glo I in the prevention of advanced glycation end product (AGE) formation in transgenic
mouse lenses. Methods. A transgenic animal line that expressed high levels of human Glo I in the lens was developed from the
C57B6 mouse strain. The role of Glo I in the inhibition of MGO-AGE formation was tested in organ-cultured lenses. Results.
Organ culture of Wt and Glo I lenses with 5 mM D, L-glyceraldehyde (GLD) enhanced MGO by 29-fold and 17-fold in Wt lenses
and Glo I lenses, respectively. Argpyrimidine levels were 192 ± 73 pmoles/mg protein, and hydroimidazolone levels were 22 ± 0.7
units/μg protein in GLD-incubated Wt lenses. In Glo I lenses, formation of AGEs was signiﬁcantly inhibited; the argpyrimidine
levels were 82 ± 18 pmoles/mg protein, and the HI levels were 2.6 ± 2.3 units/μg protein. Incubation of Wt lens proteins with 5
mM ribose for 7 days resulted in the formation of pentosidine. However, the levels were substantially higher in Glo I lens proteins
incubated with ribose. Conclusion. Our study provides direct evidence that Glo I activity plays an important role in the regulation
of AGE synthesis in the lens; while Glo I activity blocks the formation of MGO-AGEs, it might promote the formation of sugar-
derived AGEs.
1.Introduction
Lens proteins undergo numerous physicochemical changes
during aging and cataract formation. Some of the promi-
nent changes are protein crosslinking, chromophore and
ﬂuorophore adduct formation on proteins, deamidation and
truncation [1]. Several mechanisms have been proposed for
such changes, including the Maillard reaction. The Maillard
reaction is a nonenzymatic reaction of reactive carbonyls,
such as glucose and ascorbate oxidation products, with the
amino groups of proteins. The reaction proceeds through
the formation of an Amadori product which, by a series of
reactions,producesadvanced glycationend products(AGEs)
on proteins [2]. Many AGEs have been detected in the
human lens, that include, glucosepane [3], pentosidine [4],
Nε-carboxymethyllysine [5], pyrraline [6], K2P [7], and
vesperlysine [8]. While vesperlysine and K2P are lysine-
lysine crosslinking adducts, pentosidine and glucosepane
are lysine-arginine adducts. These AGEs progressively accu-
mulate in aging lenses and accumulate at a higher rate in
cataractous lenses.
Methylglyoxal (MGO) is an additional AGE precursor
in the lens. It is an α-dicarbonyl compound produced
nonenzymatically from the triose phosphate intermediates
of glycolysis [9]. MGO reacts rapidly with arginine residues
on proteins to form hydroimidazolone (HI, there are three
isomers of this product) and argpyrimidine adducts [10].
While argpyrimidine is a blue ﬂuorescent product, HI
isomers are nonﬂuorescent and nonchromophoric adducts.
MGO also reacts with the lysine residues of proteins to
produce Nε-carboxyethyl lysine [5], MOLD, and MODIC
[3, 11]. MOLD is an imidazolium salt that is formed from
a crosslinking adduct between two lysine residues, and
MODIC is a lysine-arginine crosslinking structure. These
AGEs are present in relatively high concentrations in aged
and cataractous human lenses [11–13].2 Journal of Ophthalmology
MGO is metabolized by glyoxalase and aldo-keto reduc-
tases in the lens. However, glyoxalase constitutes the major
route of metabolism [14]. Glyoxalase is comprised of two
enzymes, glyoxalase I (Glo I), which converts hemithioacetal
(formed nonenzymatically from the reaction of glutathione
and MGO) to S-D-lactoyl glutathione, and glyoxalase II (Glo
II),whichcatalyzestheconversionofS-D-lactoylglutathione
to D-lactate [15].
Glo I appears to be critical for reducing MGO con-
centrations and subsequent AGE formation in micro- and
macrovascular endothelial cells [16, 17] and for the sur-
vival of human retinal capillary pericytes in high glucose
environments [18]. Its activity in the lens is enhanced
during diabetes, possibly as a means to cope with increased
MGO concentrations [19]. In the rat lens, Glo I inhibition
led to an increase in MGO and AGE content [20]. These
ﬁndings suggest that Glo I is critical for the reduction of
MGO accumulation and AGE formation. To gain further
insight into the role of Glo I in the lens, we developed a
transgenic mouse line that speciﬁcally overexpresses human
Glo I in lens epithelial and ﬁber cells. Using lenses from
this animal model, we show that Glo I inhibits MGO-
derivedAGEformation.Surprisingly,enhancedGloIactivity
led to higher levels of a sugar-derived AGE, pentosidine,
in ribose incubated-lens proteins when compared to the
levels observed for Wt lens proteins. The ﬁndings in this
study clearly implicate Glo I in the prevention of MGO-
mediated AGE synthesis but at the same time suggest
that Glo I may enhance sugar-mediated AGE synthesis in
the lens.
2.MaterialsandMethods
M-199 medium with Earle’s salts, reduced glutathione
(GSH), 5,5 -dithiobis 2-nitro-benzoic acid (DTNB), ethyl-
enediaminetetraacetic acid (EDTA), DL-glyceraldehyde,
heptaﬂuorobutyric acid, 6-hydroxy-2, 4, 5-triamino-
pyrimidine (TRI), HEPES, trichloroacetic acid (TCA),
sodium carbonate, streptozot-1ocin, and phenylmethyl
sulfonyl ﬂuoride (PMSF) were purchased from Sigma
Chemical Co, St. Louis, MO. HI monoclonal antibody was
made in mice by immunizing with HI coupled to KLH
(Kanade et al., unpublished).
3. Generationof GlyoxalaseI
Transgenic Animals
The studies complied with the ARVO Statement on the Use
of Animals in Ophthalmic and Vision Research and were
approved by the Case Western Reserve University Institu-
tional Animal Care and Use Committee. A transgenic mouse
linewasproducedbythestandardpronuclearmicroinjection
technique. The details of the transgene DNA construct are
illustrated in Figure 1. The human glyoxalase I (Glo I) gene
was inserted between EcoR1 sites of a minigene construct
that contained a chick δ1-crystallin lens enhancer upstream
of the αA-crystallin promoter and a rabbit β-globin intron.
Human growth hormone polyA was inserted downstream
PCR primers
Kpn I
δ1-enhancer αA-P β-glo int Glo I hGH pA
EcoR I EcoR I Sac I
3.5kb
Figure 1: Human Glo I minigene construct. The human Glo I gene
was linked to the chimeric promoter that contains the mouse αA-
crystallin promoter (αA-P) and chick δ1-crystallin lens enhancer (δ
-en), which drives the expression of Glo I speciﬁcally in the lens
epithelium and ﬁber cells.
from the αA-crystallin promoter. At 2 to 3 weeks after birth,
tail biopsies were obtained, and genomic DNA was screened
for transgene integration by PCR using the forward primer
5 -TCTGAGAGCCTCTGCTGCTC -3  and the reverse
primer 5 -GGTCCATGGTGATACAAGGGAC -3 .T h e
identiﬁed founders were crossed with wild type C57BL6 to
establish a hemizygous line. Homozygous transgenic mouse
lines were established by breeding the hemizygous mice
within the same line. All experiments were performed using
lenses from the homozygous line.
4. In Situ Hybridization
In situ hybridization was performed with a 35S-labeled
riboprobe homologous to the human growth hormone
(hGH) sequences as described previously in [21].
5. Morphological Changes
Immediately after dissection, the eyes were ﬁxed in 10%
neutral-buﬀered formalin, embedded in paraﬃn, cut into
5-μm sections, and stained with hematoxylin and eosin
using the standard procedure. After rehydration in xylene
and ethanol series, paraﬃn-embedded eye sections were
treated with citrate buﬀe r( p H6 . 0 )f o r2 0 m i na t7 0 ◦C,
cooled and then incubated in 3.0% hydrogen peroxide to
block endogenous peroxidase. The sections were incubated
with streptavidin D and biotin blocking solution for 15min
each at room temperature and then in mouse-on-mouse
(M.O.M, Vector Laboratories, CA) Ig blocking solution for
1hr at room temperature. After washing in PBS, the sections
were incubated in M.O.M diluent, followed by incubation
in mouse anti-Glo I mAb [22] diluted to 24μg/ml in
PBS overnight at 4◦C. After being thoroughly washed in
PBS, the slides were incubated with M.O.M biotinylated
antimouse IgG reagent and rinsed thoroughly in PBS. The
slideswerethenincubatedinABCVectastainElitePeroxidase
(Vector Laboratories) and rinsed in PBS. The sections were
stained by incubating in 3, 3 -diaminobenzidine substrate,
rinsed thoroughly in deionized water, and counterstained
with hematoxylin. The slides were viewed with an Olympus
BX-60 upright microscope (Tokyo, Japan). Color images
were captured using a SPOT RT Slider camera (Diagnostic
Instruments, MI) connected to a Macintosh computer using
Spot software version 3.5.5.Journal of Ophthalmology 3
6.LensOrgan Culture
The mouse lenses from 8-week-old Wt and transgenic
animals were dissected out of the eye by a posterior approach
without the dissecting tools coming into direct contact with
the lens. The lenses were cultured in modiﬁed TC-199 media
according to Shamsi et al. [20]. Brieﬂy, the lenses were placed
ina24-wellplateﬁlledwith2ml/wellofmediacontaining25
mM HEPES (pH 7.4) and 0.9% sodium carbonate, 30μg/ml
streptomycin and 30U/ml penicillin. The osmolarity of the
media was measured to be ∼320 mOsm. The medium was
incubated for 2 hr in a 37◦C incubator with 5% CO2 and
95% air prior to the addition of the lenses. The lenses were
incubated for 24hr, and those that developed haziness were
discarded. The lenses were maintained for 48hr in media
containing GLD, and the media was changed after 24hr.
Lenses incubated with media alone served as the control.
After the incubation, lenses were washed with 2ml PBS twice
and frozen at −80
◦C.
7. Assay for Glo I Activity
Lenses were homogenized in 0.1M Tris-HCl buﬀer, pH
7.4, containing 100μM PMSF. After homogenization, the
extract was centrifuged at 18,000 g for 30min at 4◦C. Glo
I activity was measured by monitoring the formation of S-
D-lactoylglutathione at 240nm over a period of 5 min. The
enzyme activity was calculated from the molar extinction
coeﬃcient of S-D-lactoylglutathione (3370 cm−1at 240nm)
and expressed as μmoles of S-D-lactoylglutathione formed
per min per mg of protein.
8. MGO Estimation
MGO was estimated according to the method of Espinosa-
Mansilla et al. [23]. The lenses were homogenized in 150μl
of 10% TCA and centrifuged. One hundred microliters
of supernatant from the TCA extraction was mixed with
1mM 6-hydroxy-2, 4, 5-triaminopyrimidine (TRI) in 250μl
of sodium acetate buﬀer at pH 4.05. The mixture was
incubated at 60
◦C for 45 min. The sample was ﬁltered
through a 0.45μm centrifugal ﬁlter and injected into a C18
reversed phase HPLC column as per the previously reported
procedure in [19]. The MGO content in the samples was
calculated by comparison with known quantities of similarly
processed MGO standards, and the results were expressed as
pmoles/lens.
9.EstimationofGSH
GSH was determined according to Cui and Lou [24]. Each
lens was homogenized in 150μl of 10% TCA, and the
homogenate was centrifuged at 10,000 g for 10min. The
supernatant was used for MGO estimation, and the pellet
was used for AGE estimation (see below). Twenty microliters
of lens TCA supernatant was mixed with 10μlo fD T N B
(2mg/2.5ml methanol). The volume was adjusted to 200μl
with 1.0 M Tris-HCl buﬀer, pH 8.2 containing 0.02 M EDTA.
The absorbance of the reaction product was measured at
412nm, and the GSH level was quantiﬁed by comparing to
GSH standards.
10. HPLC Assay for Argpyrimidine
and Pentosidine
TCA-pelleted lens protein from the MGO estimation was
washed with ether and air dried overnight. The pellet was
suspended with 6 N HCl and incubated for 16 hr at 110
◦C.
The acid was evaporated in a Savant SpeedVac system, and
the pellet was resuspended in 250μl of water ﬁltered through
a0 . 4 5 μm centrifugal ﬁlter. Aliquots of all samples were
analyzed by HPLC for argpyrimidine and pentosidine as
previously described in [25, 26].
11. ELISA for Hydroimidazolone (HI)
Microplate wells were coated overnight with 5μgo fs o l u b l e
lens protein per well in 50mM carbonate buﬀer (pH 9.6)
in triplicate. The wells were then washed three times with
phosphate-buﬀered saline-Tween-20 (PBS-T) and incubated
with 50μl of diluted HI monoclonal antibody for 1 hr at
37
◦C. Following this step, the wells were washed three times
with PBS-T and incubated with 50μl of goat antimouse IgG
diluted in PBS-T (1:5000) for 1 hr at 37
◦C. After the wells
were washed with PBS-T, they were incubated with 100μl
of 3, 3 ,5 ,5  -tetramethylbenzidine substrate (Sigma). The
enzyme reaction was stopped by the addition of 50μlo f2 N
H2SO4, and the absorbance was measured at 450nm in a
Dynex MRX 5000 Microplate Reader. One unit of HI was
deﬁned as an increase in 0.01 O.D (at 450nm)/μg protein.
12.StatisticalAnalysis
Fisher’s PLSD test (Statview 5.0; SAS Institute, Inc., Cary,
NC) was used to evaluate the diﬀerences among treatment
groups. We considered P ≤ .05 to be statistically signiﬁcant.
13. Results and Discussion
Histological examination of lenses from 6-month-old
homozygous transgenic animals did not show any mor-
phological changes when compared to the lens of a Wt
mouse of a similar age (Figure 2(a)). Immunohistological
examination revealed that Glo I was overexpressed both in
epithelial cells and in outer cortical ﬁber cells (Figure 2(b)).
Glo I overexpression was further conﬁrmed by in situ
hybridization, which showed high levels of Glo I mRNA in
epithelial cells and ﬁber cells (Figure 2(c)). Glo I activity in
transgenic lenses was approximately 86-fold higher than in
Wt lenses (Figure 2(d)).
To determine if the overexpression of Glo I prevents
MGO-AGE formation, the lenses were incubated with 5mM
GLD. Direct exposure of the lenses to MGO was avoided, as
MGO becomes cytotoxic above 500μMandcausesopacityof
the lens. We have previously shown that incubation of lenses
with GLD results in high levels of MGO and MGO-AGEs
in organ-cultured rat lenses [20]. Incubation of Wt lenses4 Journal of Ophthalmology
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Figure 2: Glo I expression and activity in transgenic mouse lenses. (a) H&E staining of Wt and Glo I transgenic lenses
showed no morphological changes in 6-month old animals. No diﬀerence was noticeable between the Wt and transgenic lens. (b)
Immunohistochemistry using a monoclonal antibody for human Glo I showed human Glo I expression in epithelial cells and outer cortical
ﬁber cells. Glo I immunoreactivity was absent in Wt lenses. (c) In situ hybridization shows Glo I mRNA in outer cortical and epithelial
cells in Glo I transgenic animals. (d) Glo I activity was measured in the water-soluble lens proteins. Glo I-catalyzed formation of S-D-
lactoylglutathione from MGO and GSH was monitored at 240nm. The data are the mean ± SD from 4 lenses.
with GLD resulted in a profound accumulation of MGO.
This was signiﬁcantly reduced in Glo I lenses (Figure 3(a)),
suggesting that the overexpression of Glo I inhibited MGO
accumulation in the lens. These results are in line with
the previous reports showing that Glo I overexpression
reduced intracellular MGO levels in human umbilical vein
endothelial cells [16] and reduced MGO-AGEs in rat renal
tubular epithelial cells [27]. In addition, it has been shown
that a reduction of Glo I activity results in MGO-AGEs in
cells [17, 28], which is compatible with the present ﬁndings.
GSH is a cofactor of Glo I. Our previous study has shown
that incubation with GLD reduces GSH levels in rat lenses,
possiblybecauseofenhancedoxidation[20].Weinvestigated
whether GLD also reduced GSH in mouse lenses. Upon
incubation with GLD, GSH levels were reduced nearly
10-fold in both Wt and Glo I lenses (Figure 3(b)). Even
though the residual GSH levels were far smaller than those
present in lenses incubated without GLD, the levels found
in lenses incubated with GLD could have been suﬃcient to
support Glo I activity. This assertion is supported by the
fact that MGO levels in GLD-incubated Glo I lenses were
approximately 50% lower than those present in GLD-treated
Wt lenses (Figure 3(a)). These results are in agreement with
our previous studies with rat lenses where we found that
GSH levels, even though precipitously diminished upon
incubation with GLD, were suﬃcient to reduce the levels of
an MGO-AGE in the lens [20].
The MGO-AGE levels were reduced as a consequence
of the increased Glo I activity and decreased MGO levels.
Incubation of the lenses with GLD resulted in nearly
200pmoles/μmole amino acid argpyrimidine in Wt lenses.
This was reduced by nearly 2-fold (P<. 001) in GLD-
treated Glo I lenses (Figure 4(a)). Similarly, the HI content
was reduced nearly 10-fold (P<. 0001) in Glo I lenses when
compared to Wt lenses (Figure 4(b)). These results suggest
that Glo I regulates MGO-AGE formation in the lens. Our
results are compatible with previous studies that have shown
similar eﬀects of Glo I overexpression on the reduction of
MGO-AGEs [16, 27].
Pentosidine is an AGE that is formed as a crosslinking
adduct between a lysine and an arginine residue in proteins
[29]. We have previously shown that MGO inhibits pentosi-
dine synthesis from ribose and ascorbate [26]. We reasoned
that MGO occupies arginine residues because of its extremeJournal of Ophthalmology 5
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Figure 3: MGO and GSH levels in organ-cultured lenses. Lenses were organ cultured for 48 hr in the absence or presence of 5mM GLD.
Lenses were homogenized in 10% TCA, and supernatants were used for MGO and GSH estimation as described in the Materials and
Methods. MGO levels (a) are expressed as pmoles/lens (∗P<. 005), and GSH levels (b) are expressed as nmoles/lens. The average wet
weight of each lens was 5.5 mg. The results are the mean ± SD from 6 lenses.
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Figure 4: MGO-derived AGEs are inhibited by Glo I overexpression. (a) Argpyrimidine content in lenses cultured in the presence of GLD.
TCA precipitated lens protein was hydrolyzed by 6 N HCl and subjected to HPLC analyses as described in the Materials and Methods. The
results are the mean ± SD of 6 lenses. (
∗P <. 001). (b) HI estimation by ELISA. Microplate wells were coated overnight with 5μg of soluble
lens protein per well and incubated with a monoclonal antibody for HI followed by goat antimouse IgG. The results are the mean ± SD from
4 lenses. (
∗∗P <. 0001).
reactivity with it and thereby blocks pentosidine formation.
To test whether Glo I overexpression prevented MGO-
mediated inhibition of pentosidine synthesis, we incubated
water soluble proteins (without dialysis, to preserve GSH)
from Wt and Glo I lenses with 5mM ribose for 7 days at
pH 7.4. While the incubation of ribose with Wt lens proteins
resulted in the accumulation of pentosidine, as expected,
incubation of ribose with Glo I lens proteins resulted in even
higherconcentrations(30%more)ofpentosidine(Figure 5).
This suggeststhat MGO is generated during ribose-mediated
glycation and that MGO is metabolized by Glo I in isolated
lens proteins. In fact, in a previous study, we have shown
that MGO-mediated argpyrimidine synthesis occurs during
glycation by ribose [30], implying that MGO is produced
during the reaction. Thus, the present study conﬁrms those
results and provides a basis for the argument that Glo I6 Journal of Ophthalmology
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Figure 5: Promotion of pentosidine synthesis by Glo I overexpres-
sion.WtandGloIlenshomogenates(5mg/ml)wereincubatedwith
5mM ribose for 7 days and analyzed by HPLC for pentosidine. The
results are the mean ± SD from 3 experiments. (∗P<. 0001).
overexpression may not be the best strategy to reduce AGEs
in cells and tissues.
14. Conclusions
In conclusion, our study provides direct evidence for the
modulation of AGE synthesis by Glo I. Determining whether
MGO-mediated AGE inhibition is beneﬁcial or harmful
requires further work, as our studies have shown that
mild modiﬁcation of lens αA-crystallin makes it a better
chaperone protein [31, 32]. The chaperone property of αA-
crystallin has been proposed to play an important role in
maintaining the transparency of the aging lens. The other
ﬁnding that Glo I-mediated removal of MGO could promote
synthesis of AGEs from sugars suggests that overexpression
of Glo 1 to deplete MGO may be counterintuitive for
prevention of AGE synthesis in the lens.
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